trihexyphenidyl has been researched along with Cortical Lewy Body Disease in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, K | 1 |
| Wada, I | 1 |
| Okunomiya, T | 1 |
| Shima, A | 1 |
| Kambe, D | 1 |
| Shinde, A | 1 |
| Kageyama, T | 1 |
| Suenaga, T | 1 |
1 other study available for trihexyphenidyl and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Dropped head syndrome preceding the onset of dementia with Lewy bodies.
Topics: Aged; Brain; Cholinergic Antagonists; Female; Humans; Iofetamine; Lewy Body Disease; Magnetic Resona | 2014 |